share_log

Despite Lower Earnings Than Five Years Ago, Innoviva (NASDAQ:INVA) Investors Are up 25% Since Then

Despite Lower Earnings Than Five Years Ago, Innoviva (NASDAQ:INVA) Investors Are up 25% Since Then

儘管收益低於五年前,但Innoviva(納斯達克:INVA)投資者自那時以來已上漲25%。
Simply Wall St ·  2024/12/19 18:00

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than that, you probably want to see it rise more than the market average. Unfortunately for shareholders, while the Innoviva, Inc. (NASDAQ:INVA) share price is up 25% in the last five years, that's less than the market return. Over the last twelve months the stock price has risen a very respectable 12%.

當你長期買入並持有一隻股票時,你肯定希望它能夠提供正收益。但更重要的是,你可能希望看到它的漲幅超過市場平均水平。遺憾的是,對於股東來說,雖然Innoviva, Inc.(納斯達克:INVA)的股價在過去五年上漲了25%,但這低於市場收益。在過去的十二個月中,股票價格上漲了非常可觀的12%。

Although Innoviva has shed US$58m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.

儘管Innoviva本週市值減少了5800萬美元,但我們來看看其長期基本面趨勢,看看這些趨勢是否推動了收益。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

儘管有效市場假說仍然被一些人教授,但已經證明市場是一種反應過度的動態系統,投資者並不總是理性。通過比較每股收益(EPS)和股價變化,我們可以感受到投資者對公司的態度在一段時間內是如何變化的。

During five years of share price growth, Innoviva actually saw its EPS drop 23% per year.

在五年的股價增長中,Innoviva的每股收益實際上年均下降了23%。

Since the EPS are down strongly, it seems highly unlikely market participants are looking at EPS to value the company. The falling EPS doesn't correlate with the climbing share price, so it's worth taking a look at other metrics.

由於每股收益大幅下跌,市場參與者似乎不太可能通過每股收益來評估公司。每股收益的下跌與每股價格的上漲沒有關聯,因此值得關注其他指標。

We are not particularly impressed by the annual compound revenue growth of 1.8% over five years. So why is the share price up? It's not immediately obvious to us, but a closer look at the company's progress over time might yield answers.

我們對五年來1.8%的年複合營業收入增長並沒有特別印象。那麼,爲什麼股價會上漲呢?這對我們來說不是立刻顯而易見的,但更仔細地審視公司的進展可能會揭示答案。

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

以下圖像顯示了公司的營業收入和盈利(隨時間變化)(單擊以查看準確的數字)。

big
NasdaqGS:INVA Earnings and Revenue Growth December 19th 2024
納斯達克GS:INVA的盈利與營業收入增長 2024年12月19日

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. This free report showing analyst forecasts should help you form a view on Innoviva

值得注意的是,首席執行官的薪酬低於類似規模公司的中位數。時刻關注首席執行官的薪酬是有必要的,但更重要的問題是公司是否會在多年內增長收益。這份免費的報告展示了分析師的預測,應該能幫助你對Innoviva形成看法。

A Different Perspective

不同的視角

Innoviva shareholders are up 12% for the year. But that return falls short of the market. On the bright side, that's still a gain, and it's actually better than the average return of 4% over half a decade This suggests the company might be improving over time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that Innoviva is showing 2 warning signs in our investment analysis , and 1 of those is concerning...

Innoviva的股東今年上漲了12%。但這個回報低於市場水平。值得欣慰的是,這仍然是一個收益,實際上比過去五年的平均回報4%要好。這表明公司可能在逐漸改善。雖然考慮市場條件對股價的不同影響是非常值得的,但還有其他更重要的因素。即便如此,要注意的是,在我們的投資分析中,Innoviva顯示出兩個警告信號,其中一個令人擔憂。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

如果你更傾向於查看其他公司——一個財務狀況可能更優的公司——那麼不要錯過這個免費的公司列表,它們已經證明能夠實現盈利增長。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文中引用的市場回報反映了當前在美國交易所上市股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論